Chapter title |
Sodium diethyldithiocarbamate (imuthiol) and cancer.
|
---|---|
Chapter number | 19 |
Book title |
Biological Response Modifiers in Human Oncology and Immunology
|
Published in |
Advances in experimental medicine and biology, January 1983
|
DOI | 10.1007/978-1-4757-1410-4_19 |
Pubmed ID | |
Book ISBNs |
978-1-4757-1412-8, 978-1-4757-1410-4
|
Authors |
Renoux, G, Renoux, M, Lemarie, E, Lavandier, M, Greco, J, Bardos, P, Lang, J M, Boilleto, A, Oberling, F, Armand, J, Renoux, G., Renoux, M., Lemarie, E., Lavandier, M., Greco, J., Bardos, P., Lang, J. M., Boilletot, A., Oberling, F., Armand, J., Mussett, A., Biron, G. |
Abstract |
Sodium diethyldithiocarbamate (imuthiol), a nonantigenic, nontoxic and noncarcinogenic compound, evinces distinctive properties in recruitment and activation of T cells, and no direct influences on B cells or macrophages. The biological attributes of imuthiol (destruction of neoplastic cells, bacteria, fungi and parasites; a detoxifying influence against carcinogens or agents toxic for the liver) could strengthen its activity as a biological response modifier. Preliminary clinic testings show that imuthiol restores T cell activities and regulates the ratio among T cell subsets in cancer patients, without untoward side effects. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 5 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 2 | 40% |
Student > Doctoral Student | 1 | 20% |
Unknown | 2 | 40% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 2 | 40% |
Nursing and Health Professions | 1 | 20% |
Unknown | 2 | 40% |